📰 Cardiovascular Analytics News
Cardiovascular Analytics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cardiovascular Analytics. Real-time updates on events, politics, business and more.
November 27, 2023
In the first comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data, Truveta Research...
November 27, 2023
A new study of over 40,000 patients found that Eli Lillys Mounjaro helped them lose weight more effectively than Novo Nordisks Ozempic.
November 15, 2023
A group of 13 leading experts provides their perspectives on the top news in cardiovascular medicine from 2023, with responses ranging from novel approvals to new semaglutide data to gene therapy and more.
November 2, 2023
Cost-effectiveness data and analyses of financial impact among patients hospitalized for heart failure and treated with INPEFA included as important data selected for presentation
September 14, 2023
Explore the possibilities of cardiology in the next 50 years with 8 cardiology leaders.
November 24, 2021
Toronto, ON (PRWEB) November 24, 2021 -- The goal of cardiovascular safety pharmacology is to evaluate the effects of test substances on the most relevant
October 15, 2021
/PRNewswire/ -- Cano Health, Inc. ("Cano Health") (NYSE: CANO), a leading value-based primary care provider for seniors and underserved communities, today...